Fellowship · New York, NY
Sponsored by New York Presbyterian Hospital
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.
Nature medicine · 2022 · 466 citations · Michael Farwell
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Lancet (London, England) · 2024 · 251 citations · Randy Yeh
A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guideline.
Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2023 · 116 citations · Lionel Zuckier
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
The Journal of urology · 2021 · 322 citations · Lawrence Saperstein
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2021 · 317 citations · Lawrence Saperstein
TGF-β signaling: critical nexus of fibrogenesis and cancer.
Journal of translational medicine · 2024 · 108 citations · Kathleen Capaccione
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation.
Blood · 2025 · 50 citations · Honglei Zhang
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 62 citations · Sandra Castellanos